Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2009
12/10/2009US20090305408 Method for the rapid expansion of antigen specific t-cell
12/10/2009US20090305407 Devices and Methods for Sampling Biological Fluids
12/10/2009US20090305406 Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method
12/10/2009US20090305405 Use of tgf beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
12/10/2009US20090305404 Methods and compositions relating to blastomere-derived human embryonic stem cells
12/10/2009US20090305403 Isolation and Differentiation of Adult Hippocampal Arctic Squirrel Neural Stem Cells
12/10/2009US20090305402 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
12/10/2009US20090305401 Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
12/10/2009US20090305400 Modified chaperonin 10
12/10/2009US20090305399 for treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis
12/10/2009US20090305385 Novel Cultured Silkworm Cells Capable of Highly Efficient Baculovirus Production and Protein Production
12/10/2009US20090305384 Class II Human Histone Deacetylases, and Uses Related Thereto
12/10/2009US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009US20090305358 DNA Vector Production System
12/10/2009US20090305357 Chondroitin polymerase and dna encoding the same
12/10/2009US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides
12/10/2009US20090305346 Engineered cleavage half-domains
12/10/2009US20090305344 Chimeric alphavirus replicon particles
12/10/2009US20090305343 Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing
12/10/2009US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity
12/10/2009US20090305340 Altered peptide ligands of gad65
12/10/2009US20090305338 Plant cell lines established from the medicinal plant veratrum californicum
12/10/2009US20090305329 Intracellular targeting of molecules
12/10/2009US20090305326 Microfluidic device and method for coupling discrete microchannels and for co-culture
12/10/2009US20090305325 Method for Preservation of Human Hematopoietic Stem or Progenitor Cells
12/10/2009US20090305324 Cytotoxic t-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
12/10/2009US20090305320 Method of detecting activation of notch signal transmission system
12/10/2009US20090305311 C4d/c4b standard for quantitative flow cytometry of humoral transplant rejection
12/10/2009US20090305309 Methods and Compositions for Detecting Neoplastic Cells
12/10/2009US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009US20090305281 Novel inhibitors of retroviral reverse transcriptace
12/10/2009US20090305271 In Vitro Assay Based on Camp Levels Modulated by Gi-Coupled Receptors
12/10/2009US20090305241 DNA demethylases and uses thereof
12/10/2009US20090305236 Methods of enriching fetal cells
12/10/2009US20090305228 Potentiation of Apoptosis by Monoclonal Antibodies
12/10/2009US20090305227 Hiv-1 latency model for high throughput screening
12/10/2009US20090305224 Methods for the Cryopreservation of Mammalian Cells
12/10/2009US20090304901 Modulating plant protein levels
12/10/2009US20090304889 Plants having an increased content of amino sugars
12/10/2009US20090304825 Estrogenic extracts for use in treating vaginal and vulvar atrophy
12/10/2009US20090304817 Glycosylation Variants of Ricin-Like Proteins
12/10/2009US20090304781 Master gene of arteriogenesis
12/10/2009US20090304765 R-ras activity in vascular regulation
12/10/2009US20090304738 Methods for Enhancing Immune Responses
12/10/2009US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof
12/10/2009US20090304721 Toxin conjugated eph receptor antibodies
12/10/2009US20090304717 Immuno-RNA-Constructs
12/10/2009US20090304713 Binding agents
12/10/2009US20090304710 Novel anti-cd38 antibodies for the treatment of cancer
12/10/2009US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009US20090304702 Gene expressed in prostate cancer and methods of use
12/10/2009US20090304701 Antibodies binding il-1 related polypeptides
12/10/2009US20090304696 Single Chain FC Polypeptides
12/10/2009US20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof
12/10/2009US20090304690 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
12/10/2009US20090304686 Interfering in activation of an immune cell by influencing interaction of lair and collagen
12/10/2009US20090304684 Methods and compositions for needleless delivery of antibodies
12/10/2009US20090304678 Means for Inhibiting the Expression of Protein Kinase 3
12/10/2009US20090304674 Methods for treating disease by regulating cll cell survival
12/10/2009US20090304666 Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
12/10/2009US20090304664 Modulators of alpha-synuclein toxicity
12/10/2009US20090304660 G-csf derivative for inducing immunological tolerance
12/10/2009US20090304659 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+ t cells
12/10/2009US20090304658 Method of proliferating lak cell
12/10/2009US20090304657 Chimeric t cell receptors and related materials and methods of use
12/10/2009US20090304654 Methods for isolating adipose-derived stem cells and therapeutic use thereof
12/10/2009US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/10/2009US20090304652 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells
12/10/2009US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors
12/10/2009US20090304650 Repair of the Bone Marrow Vasculature
12/10/2009US20090304647 Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof
12/10/2009US20090304646 Multipotent/Pluripotent Cells and Methods
12/10/2009US20090304645 In vitro engineered, regenerated urinary tract tissue compositions and methods for producing same
12/10/2009US20090304644 Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue
12/10/2009US20090304643 Methods of Preparing and Characterizing Mesenchymal Stem Cell Aggregates and Uses Thereof
12/10/2009US20090304642 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
12/10/2009US20090304641 Methods and Compositions for Regulating Gene Expression
12/10/2009US20090304640 Transfection of Collagen-Producing Cells
12/10/2009US20090304639 Method for preparing an organ for transplantation
12/10/2009US20090304590 Therapeutic compositions and methods
12/10/2009US20090304588 Biologically excitable cells
12/10/2009US20090304579 Cancerous Disease Modifying Antibodies
12/10/2009US20090304578 Cancerous Disease Modifying Antibodies
12/10/2009DE19612966B4 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren MDCK cells and methods for the propagation of influenza virus
12/10/2009CA2763791A1 Pluripotency associated epigenetic factor
12/10/2009CA2728556A1 Method for assessing embryotoxicity
12/10/2009CA2727003A1 Organ-on-a-chip-device
12/10/2009CA2726990A1 Methods for the production of ips cells using non-viral approach
12/10/2009CA2726979A1 Three dimensional tissues for high-throughput assays
12/10/2009CA2726804A1 Xbp1, cd138, and cs1 peptides
12/10/2009CA2726364A1 6-substituted estradiol derivatives and methods of use
12/10/2009CA2726345A1 Interleukin-1 alpha abs and methods of use
12/10/2009CA2726341A1 Human facilitating cells
12/10/2009CA2724678A1 Novel treatment of heart diseases
12/09/2009EP2130922A1 Improved halohydrin epoxidase
12/09/2009EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009EP2130919A1 IL-21 antagonists
12/09/2009EP2130915A1 Cell capable of expressing lacritin at high level
12/09/2009EP2130914A1 Novel glycosyltransferase and polynucleotide encoding the same
12/09/2009EP2130911A1 Feeder cell derived from tissue stem cell